Skip to main content
SpringerLink
Log in

Thiazide prescriptions are not associated with lower urolithiasis: a Japanese epidemiologic study

  • Urology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The data that support the findings of this study are available from MDV Co., Ltd.; however, these were used under license for the current study, and are, therefore, not publicly available.

References

  1. Yendt ER, Cohanim M (1978) Prevention of calcium stones with thiazides. Kidney Int 13:397–409. https://doi.org/10.1038/ki.1978.58

    Article  CAS  PubMed  Google Scholar 

  2. Dhayat NA, Bonny O, Roth B et al (2023) Hydrochlorothiazide and prevention of kidney-stone recurrence. N Engl J Med 388:781–791. https://doi.org/10.1056/NEJMoa2209275

    Article  CAS  PubMed  Google Scholar 

  3. Dapagliflozin and hydrochlorothiazide in recurring kidney stone patients. ClinicalTrials.gov. NCT05443932. https://clinicaltrials.gov/ct2/show/NCT05443932

  4. Li DF, Gao YL, Liu HC, Huang XC, Zhu RF, Zhu CT (2020) Use of thiazide diuretics for the prevention of recurrent kidney calculi: a systematic review and meta-analysis. J Transl Med 18:106. https://doi.org/10.1186/s12967-020-02270-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Anan G, Kikuchi D, Hirose T, Ito H, Nakayama S, Mori T (2023) Impact of sodium-glucose cotransporter-2 inhibitors on urolithiasis. Kidney Int Rep. 8:925–928. https://doi.org/10.1016/j.ekir.2023.01.034

    Article  PubMed  PubMed Central  Google Scholar 

  6. Anan G, Hirose T, Kikuchi D et al (2022) Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation. Pharmacol Res 186:106524. https://doi.org/10.1016/j.phrs.2022.106524

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Japan Society for the Promotion of Science (No. 22K16822).

Author information

Authors and Affiliations

  1. Department of Urology, Yotsuya Medical Cube, 7 Nibancho, Chiyoda-ku, Tokyo, 102-0084, Japan

    Go Anan

  2. Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan

    Go Anan

  3. Department of Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan

    Daisuke Kikuchi & Kouji Okada

  4. Division of Nephrology and Endocrinology, Tohoku Medical and Pharmaceutical University, Sendai, Japan

    Takuo Hirose & Takefumi Mori

  5. Division of Integrative Renal Replacement Therapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan

    Takuo Hirose & Takefumi Mori

  6. Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, Sendai, Japan

    Takuo Hirose

  7. Division of Clinical Pharmaceutics and Pharmacy Practice, Tohoku Medical and Pharmaceutical University, Sendai, Japan

    Kouji Okada

Authors
  1. Go Anan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daisuke Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takuo Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouji Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takefumi Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by GA and DK. GA and DK drafted the first version of the manuscript; TH, KO, and TM helped revise the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Go Anan.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

The study was approved by the ethics committee of Tohoku Medical and Pharmaceutical University Hospital, Japan (Protocol 2020–2–253).

Informed consent

Informed consent was waived for anonymized data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anan, G., Kikuchi, D., Hirose, T. et al. Thiazide prescriptions are not associated with lower urolithiasis: a Japanese epidemiologic study. Int Urol Nephrol 55, 2225–2226 (2023). https://doi.org/10.1007/s11255-023-03671-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03671-5

Keywords

Search

Navigation